Concentrix [CNXC] vs Epam Systems [EPAM] Detailed Stock Comparison
Concentrix
NASDAQ
Loading...
Epam Systems
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Concentrix wins in 9 metrics, Epam Systems wins in 10 metrics, with 0 ties. Epam Systems appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Concentrix | Epam Systems | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 12.99 | 23.93 | Concentrix |
| Price-to-Book Ratio | 0.70 | 2.54 | Concentrix |
| Debt-to-Equity Ratio | 135.96 | 4.44 | Epam Systems |
| PEG Ratio | -0.36 | -2.73 | Epam Systems |
| EV/EBITDA | 6.03 | 11.83 | Concentrix |
| Profit Margin (TTM) | 2.54% | 7.91% | Epam Systems |
| Operating Margin (TTM) | 6.83% | 9.63% | Epam Systems |
| EBITDA Margin (TTM) | 6.83% | 9.63% | Epam Systems |
| Return on Equity | 5.85% | 11.35% | Epam Systems |
| Return on Assets (TTM) | 3.78% | 8.49% | Epam Systems |
| Free Cash Flow (TTM) | $428.73M | $527.02M | Epam Systems |
| Dividend Yield | 3.07% | N/A | N/A |
| 1-Year Return | -25.56% | -12.14% | Epam Systems |
| Price-to-Sales Ratio (TTM) | 0.31 | 1.84 | Concentrix |
| Enterprise Value | $8.51B | $8.45B | Concentrix |
| EV/Revenue Ratio | 0.88 | 1.67 | Concentrix |
| Gross Profit Margin (TTM) | 35.09% | 28.77% | Concentrix |
| Revenue per Share (TTM) | $150 | $89 | Concentrix |
| Earnings per Share (Diluted) | $3.65 | $7.00 | Epam Systems |
| Beta (Stock Volatility) | 0.58 | 1.67 | Concentrix |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Concentrix vs Epam Systems Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Concentrix | 4.90% | 8.05% | -14.47% | -7.35% | 12.90% | 19.59% |
| Epam Systems | 5.14% | 10.93% | 3.69% | -3.14% | -15.64% | -23.66% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Concentrix | -25.56% | -60.16% | -34.91% | -34.91% | -34.91% | -34.91% |
| Epam Systems | -12.14% | -58.60% | -46.38% | 143.49% | 1,153.22% | 1,153.22% |
Performance & Financial Health Analysis: Concentrix vs Epam Systems
| Metric | CNXC | EPAM |
|---|---|---|
| Market Information | ||
| Market Cap | $2.99B | $9.33B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 566,426 | 1,011,380 |
| 90 Day Avg. Volume | 639,722 | 740,830 |
| Last Close | $52.07 | $174.95 |
| 52 Week Range | $36.28 - $77.00 | $138.15 - $269.00 |
| % from 52W High | -32.38% | -34.96% |
| All-Time High | $208.48 (Feb 07, 2022) | $725.40 (Nov 01, 2021) |
| % from All-Time High | -75.02% | -75.88% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.02% | 0.18% |
| Quarterly Earnings Growth | -0.37% | -0.11% |
| Financial Health | ||
| Profit Margin (TTM) | 0.03% | 0.08% |
| Operating Margin (TTM) | 0.07% | 0.10% |
| Return on Equity (TTM) | 0.06% | 0.11% |
| Debt to Equity (MRQ) | 135.96 | 4.44 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $67.99 | $65.85 |
| Cash per Share (MRQ) | $5.44 | $18.70 |
| Operating Cash Flow (TTM) | $713.97M | $449.58M |
| Levered Free Cash Flow (TTM) | $689.82M | $540.61M |
| Dividends | ||
| Last 12-Month Dividend Yield | 3.07% | N/A |
| Last 12-Month Dividend | $1.62 | N/A |
Valuation & Enterprise Metrics Analysis: Concentrix vs Epam Systems
| Metric | CNXC | EPAM |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 12.99 | 23.93 |
| Forward P/E | 3.85 | 14.97 |
| PEG Ratio | -0.36 | -2.73 |
| Price to Sales (TTM) | 0.31 | 1.84 |
| Price to Book (MRQ) | 0.70 | 2.54 |
| Market Capitalization | ||
| Market Capitalization | $2.99B | $9.33B |
| Enterprise Value | $8.51B | $8.45B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.88 | 1.67 |
| Enterprise to EBITDA | 6.03 | 11.83 |
| Risk & Other Metrics | ||
| Beta | 0.58 | 1.67 |
| Book Value per Share (MRQ) | $67.99 | $65.85 |
Financial Statements Comparison: Concentrix vs Epam Systems
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CNXC | EPAM |
|---|---|---|
| Revenue/Sales | $2.37B | $1.30B |
| Cost of Goods Sold | $1.52B | $952.01M |
| Gross Profit | $855.90M | $349.68M |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | $168.87M | $99.33M |
| EBITDA | $334.50M | $151.42M |
| Pre-Tax Income | $100.79M | $94.42M |
| Income Tax | $30.54M | $20.94M |
| Net Income (Profit) | $70.26M | $73.48M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CNXC | EPAM |
|---|---|---|
| Cash & Equivalents | $308.00M | $1.17B |
| Total Current Assets | $2.96B | $2.42B |
| Total Current Liabilities | $1.79B | $789.12M |
| Long-Term Debt | $4.90B | $118.67M |
| Total Shareholders Equity | $4.03B | $3.64B |
| Retained Earnings | $1.24B | $2.47B |
| Property, Plant & Equipment | $0 | $327.67M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CNXC | EPAM |
|---|---|---|
| Operating Cash Flow | $231.10M | $82.27M |
| Capital Expenditures | $-55.79M | $-9.33M |
| Free Cash Flow | $180.74M | $14.83M |
| Debt Repayment | $-1.45B | $-684,000 |
| Common Stock Repurchase | $-46.82M | $-160.00M |
Short Interest & Institutional Ownership Analysis
| Metric | CNXC | EPAM |
|---|---|---|
| Shares Short | 7.06M | 1.73M |
| Short Ratio | 10.29 | 3.16 |
| Short % of Float | 0.13% | 0.04% |
| Average Daily Volume (10 Day) | 566,426 | 1,011,380 |
| Average Daily Volume (90 Day) | 639,722 | 740,830 |
| Shares Outstanding | 64.24M | 56.87M |
| Float Shares | 35.84M | 53.79M |
| % Held by Insiders | 0.16% | 0.04% |
| % Held by Institutions | 0.97% | 0.97% |
Dividend Analysis & Yield Comparison: Concentrix vs Epam Systems
| Metric | CNXC | EPAM |
|---|---|---|
| Last 12-Month Dividend | $1.62 | N/A |
| Last 12-Month Dividend Yield | 3.07% | N/A |
| 3-Year Avg Annual Dividend | $1.30 | N/A |
| 3-Year Avg Dividend Yield | 0.44% | N/A |
| 3-Year Total Dividends | $3.89 | N/A |
| Ex-Dividend Date | Jul 25, 2025 | N/A |